Bioceramics for Osteogenesis, Molecular and Cellular Advances

Advances in Experimental Medicine and Biology

Volumn 760, Issue , 2012, Pages 134-147

  Demirkiran, Hande ^a  

^a Alvimedica   (Turkey)

Author keywords

Bioactive Glass; Bone Repair; Bone Tissue Engineering; Calcium Phosphate; Simulated Body Fluid

Indexed keywords

BIOCERAMICS; BIOMATERIAL;

BIOLOGICAL ACTIVITY; BODY FLUID; BONE DEVELOPMENT; BONE GROWTH; BONE MINERALIZATION; BONE REMODELING; BONE STRUCTURE; BONE TISSUE; CLINICAL STUDY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; TISSUE ENGINEERING; TISSUE REGENERATION; BONE DISEASE; BONE PROSTHESIS; CERAMICS; GENETICS; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

BIOCOMPATIBLE MATERIALS; BONE DISEASES; BONE SUBSTITUTES; CERAMICS; HUMANS; OSTEOGENESIS; TISSUE ENGINEERING;

EID: 84872780668     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-1-4614-4090-1_9     Document Type: Chapter

References (83)

1. Hench LL and Wilson 1. In: An Introduction to Bioceramics. Singapore, World Scientific Publishing Co. Pte. Ltd, 1993:406.
2. Tator C, Fehlings M. Review ofthe secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms..J Neurosurg 1991; 75:15-26.
3. Hench LL. Bioceramics: From concept to clinic. J Am Ceram Soc 1991; 74(7): 1487-151 O.
4. Heness G and Ben-Nissan B. Innovative Bioceramics. Materials Forum 2004; 27: 104-114.
5. Veljovic D, Jancic-Hajneman R, Balac I. The effect of the shape and size of the pores on the mechanical properties of porous HAP-based bioceramics. Ceramics InternationaI2011; 37(2):471-479.
6. Navarro M, Michiardi A, Castano O. Biomaterials in orthopaedics. J R Soc Interface 2008; 5(27): 1137-1158.
7. Tator C, Fehlings M. Review ofthe secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms..J Neurosurg 1991; 75:15-26.
8. Dubok VA. Bioceramics: Yesterday, today, tomorrow. Poroshkovaya Metallurgiya 2000; (7-8):69-87.
9. Lobo SE, Arinzeh TL. Biphasic calcium phosphate ceramics for bone regeneration and tissue engineering applications. Materials 20 I 0; 38: 15-826.
10. Colilla M, Manzano M and V allet-Regi M. Recent advances in ceramic implants as drug delivery systems for biomedical applications. IntJ Nanomedicine 2008; 3(4):403-414.
11. Daoquan T, Xiya Z. Research and development of bioceramics (II). Journal of Wuhan University of Technology 1998; 13(2):55-61.
12. Barrere F, Blitterswijk CA, Groot K. Bone regeneration: molecular and cellular interactions with calcium phosphate ceramics. International Journal of Medicine 2006; 1(3):317-332.
13. Best SM, Porter AE, Thian ES. Bioceramics: Past, present and for the future. J Eur Ceram Soc 2008; 28(7): 1319-1327.
14. PattanayakDK, Rao BT, Mohan TRR. Calcium phosphate bioceramics and bioceramic composites. Journal of Sol-Gel Science and Technology 2010; 1-16.
15. Hong Y, Fan H, Li B. Fabrication, biological eflects and medical applications of calcium phosphate nanoceramics. Materials Science and Engineering 2010; 70(3-6):225-242.
16. Li S, Izui H, Okano M. Densification, Microstructure, and Behavior of Hydroxyapatite Ceramics Sintered by using Spark Plasma Sintering. Journal of Engineering Materials and Technology, Transactions of the ASME 2008; 130(3):0310121-0310127.
17. Lin K, Pan.I, Chen Y. Adsorption of phenol from aqueous solution by hydroxyapatite nanopowders. Part II: Kinetic, equilibrium and thermodynamic studies. ICBBE 2008, 1:3119-3122.
18. Morks MF, Kobayashi A. Mictostructural characterization and mechanical properties of plasma sprayed hydroxyapatite coatings. Ceramic Transactions 2007; 198:389-394.
19. Heleno RA, Wagner NS, Branco JRT. Performance evaluation of hydroxyapatite coatings thermally sprayed on surgical fixation pins. Key Eng Mat 2009; 396-398:69-75.
20. Jiang W, Wang WD, Shi XH. The effects of hydroxyapatite coatings on stress distribution near the dental implant-bone interface. Appl Surf Sci 2008; 255(2):273-275.
21. Tator C, Fehlings M. Review ofthe secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms..J Neurosurg 1991; 75:15-26.
22. Roeder RK, Converse GL, Kane RJ. Hydroxyapatite-reinforced polymer biocomposites for synthetic bone substitutes..10M 2008; 60(3):38-45.
23. Dupraz AMP, de Wtin JR, Meer SATvd. Characterization of silane-treated hydroxyapatite powders for use as filler in biodegradable composites..J Biomed Mater Res 1996; 30(2):231-238.
24. Morgan JP, Dauskardt RH. Notch strength insensitivity of self-setting hydroxyapatite bone cements. J Mater Sci: Mater Med 2003; 14(7):647-653.
25. Friedman CD, Costantino PD, Takagi S. BoneSource™ hydroxyapatite cement: A novel biomaterial for craniofacial skeletal tissue engineering and reconstruction..J Biomed Mat Res 1998; 43(4):428-432.
26. Zhang Y, Xu HHK, Takagi S. In-situ hardening hydroxyapatite-based scaffold for bone repair. J Mater Sci: Mater Med 2006; 17(5):437-445.
27. Renghini C, Girardin E, FominAS. Plasma sprayed hydroxyapatite coatings from nanostructured granules. Mat Sci Eng B-Solid 2008; 152(1-3):86-90.
28. Sandeep G, Varma HK, Kumary TV. Characterization of novel bioactive glass coated hydroxyapatite granules in correlation with in vitro and in vivo studies. Trends in Biomaterials and Artificial Organs 2006; 19(2):99-107.
29. Bellucci D, Cannillo V, SolaA. A New Potassium-Based Bioactive Glass: Sintering Behaviour and Possible Applications for Bioceramic Scaffolds. Ceram Int 2011; 37(1): 145-157.
30. Wang M. Bioactive calcium phosphates and nanocomposite scaffolds for bone tissue engineering. In: Narayan R, McKittrick J, eds. Advances in Bioceramics and Biotechnology, Vol. 218. Hoboken, John Wiley and Sons 2010: 175-183.
31. loku K. Tailored bioceramics of calcium phosphates for regenerative medicine..J Ceram Soc Jpn 2010; 118(1381):775-783.
32. Feito MJ, Lozano RM, Alcaide M. Immobilization and Bioactivity Evaluation of FGF-I and FGF-2 on Powdered Silicon-Doped Hydroxyapatite and their Scaffolds for Bone Tissue Engineering. J Mater Sci Mater Med 2010; 1-12.
33. Duan B, and Wang M. Immobilization of heparin on gelatin modified three-dimensional osteoconductive Ca-P/PHBV nanocomposite scaffolds. In: Narayan R, McKittrick.I, eds. Advances in Bioceramics and Biotechnology, Vol. 218. Hoboken, John Wiley and Sons 2010:43-51.
34. Bai F, Wang Z, Lu J. The correlation between the internal structure and vascularization of controllable porous bioceramic materials in vivo: A quantitative study. Tissue Eng Part A 2010; 16(12):3791-3803.
35. Deisinger U. Generatingporous ceramic scaffolds: Processing and properties. Key Eng Mat201 0;441: 155-179.
36. Tator C, Fehlings M. Review ofthe secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms..J Neurosurg 1991; 75:15-26.
37. Oliveira JM, Silva SS, Malafaya, PB. Macroporous hydroxyapatite scaffolds for bone tissue engineering applications: Physicochemical characterization and assessment of rat bone marrow stromal cell viability. J Biomed Mater Res-A 2009; 91(1):175-186.
38. Tian J, Dong L, Wang C. Tissue engineering scaflolds of bioceramics and new bone growth, Key Eng Mat 2008; 368:1161-1165.
39. Kundu B, Lemos A, Soundrapandian C. Development of porous HAp and-TCP scaffolds by starch consolidation with foaming method and drug-chitosan bilayered scaffold based drug delivery system. J Mater Sci: Mater Med 2010; 21(11):2955-2969.
40. Mourino V, Boccaccini AR. Bone tissue engineering therapeutics: Controlled drug delivery in three-dimensional scaflolds. J R Soc 1nterface 2010; 7(43):209-227.
41. Mickiewicz RA. Polymer-calcium phosphate composites for use as an injectable bone substitute. Massachusetts 1nstitute of Technology 1998; 4-14.
42. Currey JD. Mechanical properties of vertebrate hard tissues. PI Mech Eng H 1998; 212:399-411.
43. Qin T, Yang Z, Mo X. Chemical Composition and Mechanical Properties ofBio-Derived Compact Bone Scaffolds. Key Eng Mat 2006; 309-311 (11):891-894.
44. Athanasiou KA, Zu CF, Lanctot DR. Fundamentals of biomechanics in tissue engineering of bone. Tissue Eng 2000; 6:361-381.
45. Ravaglioli A, and Krajewski A. Bioceramics: Materials, Properties, Applications. London, New York: Chapman and Hall 1991.
46. Petite H, and Quarto R. Engineered Bone. Austin: Landes Bioscience 2005: 225.
47. Weiner S, Addadi L and Wagner HD. Materials design in biology. Mat Sci Eng C-Biomim 2000; 11(1 ):1-8.
48. Cao W, Bioactive materials. Ceram 1nt 1996; 22(6):493-507.
49. Tator C, Fehlings M. Review ofthe secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms..J Neurosurg 1991; 75:15-26.
50. Epple M, and Baeuerlein E. Handbook of Biomineralization. Weinheim, Wiley-VCH Verlag GmbH and Co 2009: 424.
51. Tator C, Fehlings M. Review ofthe secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms..J Neurosurg 1991; 75:15-26.
52. factorβ production in normal adult human osteoblast-like cells in vitro. J Bone Miner Res 1992; 7(11): 1281-1289.
53. Ducheyne P, Radin S, King I.. Effect of calcium phosphate ceramic composition and structure on in vitro behavior. I. Dissolution. J Biomed Mater Res 1993; 27(1):25-34.
54. Radin SR, Ducheyne P. Effect of bioactive ceramic composition and structure on in vitro behavior. 111. Porous versus dense ceramics. J Biomed Mater Res 1994; 28(11):1303-1309.
55. Kontonasaki E, Zorba T, Papadopoulou I.. Hydroxy carbonate apatite formation on particulate bioglass in vitro as a function oftime. Crys Res Technol2002; 37(11): 1165-1171.
56. Xin R, Leng Y, Chen J. A comparative study of calcium phosphate formation on bioceramics in vitro and in vivo. Biomaterials 2005; 26(33):6477-6486.
57. Chatzistavrou X, Chrissafis K, Kontorasaki E. Sinteredhydroxyapatite/bioactive glass composites: Thermal Analysis and Bioactivity. Key Eng Mat 2006; 309-311:167-170.
58. Santos JD, Jha LJ, Monteiro FJ. In vitro calcium phosphate formation on SiO,-Na20-CaO-P205 glass reinforced hydroxyapatite composite: A study by XPS analysis. J Mater Sci: Mater Med 1996; 7(3): 181-185.
59. Jha LJ, Santos JD, Knowles Jc. Characterization of apatite layer formation on P20 5-CaO, P,05-CaO-Na,O, and P,05-CaO-Na,O-A1,03 glass hydroxyapatite composites. J Biomed Mater Res 1996; 31 (4):481-486.
60. Lee E, Kim H, Kim H. Production of hydroxyapatite/bioactive glass biomedical composites by the hot-pressing technique. JAm Ceram Soc 2006; 89(11):3593-3596.
61. Skipper LJ, Sowrey FE, Pickup OM. Structural studies of bioactivity in sol-gel-derived glasses by x-ray spectroscopy. J Biomed Mater Res-A 2004; 70A(2):354-360.
62. Skipper LJ, Sowrey FE, Pickup DM. The atomic-scale interaction ofbioactive glasses with simulated body fluid. Mater Sci Forum 2005; 480-481: 21-26.
63. Kokubo T. Bioactive glass ceramics: Properties and applications. Biomaterials 1991; 12:155-163.
64. Kokubo T, Takadama H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 2006; 27(15):2907-2915.
65. Ohgushi H, Caplan A1. Stem cell technology and bioceramics: From cell to gene engineering. J Biomed Mater Res 1999; 48(6):913-927.
66. Silver lA, Deas J, Erecinska M. 1nteractions ofbioactive glasses with osteoblasts in vitro: effects of 45S5 bioglass, and 58S and 77S bioactive glasses on metabolism, intracellular ion concentrations and cell viability. Biomaterials 2001; 22(2):175-185.
67. Ozawa S, Kasugai S. Evaluation of implant materials (hydroxyapatite, glass-ceramics, titanium) in rat bone marrow stromal cell culture. Biomaterials 1996; 17(1):23-29.
68. Vrouwenvelder WCA, Groot CG, de Groot K. Histological and biochemical evaluation of osteoblasts cultured on bioactive glass, hydroxylapatite, titanium alloy, and stainless steel. J Biomed Mater Res 1993; 27(4):465-475.
69. Huang Y, Jin X, Zhang X. In vitro and in vivo evaluation of akermanite bioceramics for bone regeneration. Biomaterials 2009; 30(28):5041-5048.
70. 4 in a silicate matrix. Mat Sci Eng C-Biomim 2010; 30(2):263-272.
71. Kotobuki N, loku K, Kawagoe D. In vitro osteogenic activity of rat mesenchymal cells cultured on transparent-tricalcium phosphate ceramics. Key Eng Mat 2005; 284-286:663-666.
72. Koller MR, Palsson BO, and Masters JRW. Human Cell Culture Volume IV: Primary Hematopoietic Cells. New York, Kluwer Academic Publishers 2002: 342.
73. Krebsbach PH, Kuznetsov SA, Bianco P. Bone marrow stromal cells: Characterization and clinical application. CritRev Oral Bioi M 1999; 10(2):165-181.
74. MeijerGJ, Bruijn JD, Koole Ret at. Cell-cased bone tissue engineering. Pl os Medicine; 2007; 4(2):260-264.
75. Frohlich M, Grayson WL, Wan LQ. Tissue engineered bone grafts: Biological requirements, tissue culture and clinical relevance. Current Stem Cell Research and Therapy 2008; 3(4):254-264.
76. Oh S, Oh N, Appleford M. Bioceramics for tissue engineering applications-A review. Am J Biochem Biotechnol 2006; 2(2):49-56.
77. Bock G, and Goode 1. Tissue Engineering of Cartilage and Bone. Chichester, John Wiley and Sons Inc: 2003:251.
78. Zhang Z, Teoh SH, Teo EY. A comparison ofbioreactors for culture of fetal mesenchymal stem cells for bone tissue engineering. Biomaterials 2010; 31(33):8684-8695.
79. Chen H, Hu Y. Bioreactors for tissue engineering. Biotechnol Lett 2006; 28( 18): 1415-1423.
80. Albee FH. Studies in bone growth. Triple calcium phosphate as a stimulus to osteogenesis. Ann Surg 1920; 732-736.
81. Nihouannen D, Duval L, Lecomte A. Interactions of total bone marrow cells with increasing quantities of macroporous calcium phosphate ceramic granules. J Mater Sci: Mater Med 2007; 18: 1983-1990.
82. Fathi MH, Hanifi A, Mortazavi V. Preparation and bioactivity evaluation of bone-like hydroxyapatite nanopowder. J Mater Process Tech 2008; 202(1-3):536-542.
83. Eniwumide JO, Yuan H, Cartmell SH. Ectopic bone formation in bone marrow stem cell seeded calcium phosphate scaffolds as compared to autograft and (cell seeded) allograft. European Cells and Materials 2007; 1430-1439.